PSNL

Personalis (PSNL)

Personalis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PSNL

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/22	05:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/06/15	07:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/06/14	19:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2023/06/14	08:01	Business Wire	Dr. Kenneth J. Widder Joins Personalis Board of Directors	NASDAQ:PSNL	Personalis Inc
2023/06/10	05:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2023/05/30	21:00	Business Wire	Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023	NASDAQ:PSNL	Personalis Inc
2023/05/20	08:00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/05/20	07:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/05/20	07:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/05/20	07:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/05/20	06:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/05/20	06:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/05/20	06:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/05/17	05:19	Business Wire	Personalis、国立がん研究センター東病院、小野薬品が提携、直腸がん免疫療法反応の予測向上へ	NASDAQ:PSNL	Personalis Inc
2023/05/16	21:00	Business Wire	Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer	NASDAQ:PSNL	Personalis Inc
2023/05/16	05:30	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PSNL	Personalis Inc
2023/05/04	05:13	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PSNL	Personalis Inc
2023/05/04	05:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2023/05/04	05:01	Business Wire	Personalis Reports First Quarter 2023 Financial Results	NASDAQ:PSNL	Personalis Inc
2023/05/02	21:00	Business Wire	Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer	NASDAQ:PSNL	Personalis Inc
2023/04/20	05:01	Business Wire	Personalis to Announce First Quarter 2023 Financial Results	NASDAQ:PSNL	Personalis Inc
2023/04/06	05:01	Business Wire	Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference	NASDAQ:PSNL	Personalis Inc
2023/04/05	21:45	Business Wire	Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study	NASDAQ:PSNL	Personalis Inc
2023/03/22	21:55	Business Wire	Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023	NASDAQ:PSNL	Personalis Inc
2023/03/22	07:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/03/22	06:57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/03/09	06:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2023/03/07	22:55	Business Wire	Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay	NASDAQ:PSNL	Personalis Inc
2023/03/03	06:05	Business Wire	Personalis Appoints Christopher Hall as Chief Executive Officer	NASDAQ:PSNL	Personalis Inc
2023/02/24	07:25	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PSNL	Personalis Inc